Fundraising Fox

Photonicare

Durham, US · Delaware corporation · 8 known investors

photoni.care ↗

PhotoniCare develops OtoSight, an FDA-cleared optical coherence tomography device for non-invasive assessment and monitoring of middle ear infections in healthcare facilities. The technology is designed for physicians treating ear-related conditions and offers improved accuracy over traditional otoscope methods.

Deep TechDigital HealthHealthtechMedical Devicesin /photonicare@photonicare

Founders & leadership

RS
Ryan SheltonCEO
SB
Stephen BoppartCMO
CVCary Vance
Cary VanceExecutive

Board

PZ
Patrick ZellerBoard director
DGDale Grogan
Dale GroganinBoard directorManaging Partner at Michigan Capital Network
DZ
Dr. Zishan HaroonBoard director
GD
Gary DurackMember of the Board of Directors

Investors · 8

First Leaf CapitalChampaign-Urbanavia Mark Aardsma · inferred
Healthtech CapitalSilicon Valley
Illinois VenturesChampaign
Michigan Capital NetworkGrand Rapids
Michigan RiseEast Lansing · $50K – $150K
OSF VenturesPeoria
Plains VenturesOklahoma City · $250K – $1M
Sony Ventures CorporationreportedTokyo

Competitors · 1

by search overlap
HealthPartners369 shared keywordsHealthPartners is a health system and health insurance organization that provides medical care and coverage while working to reduce health disparities in the communities it serves. It focuses on advancing health equity in chronic disease care, preventive screenings, and maternal and child health.

Companies competing with Photonicare for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements

$19.9M disclosed across 8 rounds · 2015–2024

▶$4.6MraisedNov 2024 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick ZellerDirector
  • Cary . VanceExecutive Officer, Director
  • Dale GroganDirector
  • Dr. Zishan HaroonDirector
Offering amount
$9M
Amount sold
$4.6M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedDec 2023 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon SoderbergDirector
  • Jeff HydarExecutive Officer
  • Cary . VanceExecutive Officer, Director
  • Jon SunthimerDirector
  • Ryan SheltonExecutive Officer, Director
  • Eric BensonExecutive Officer
  • Dale GroganDirector
  • Steve MeyerDirector
Offering amount
$5.8M
Amount sold
$4M
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMay 2023 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan . SheltonExecutive Officer, Director
  • Cary VanceExecutive Officer
  • Jeff HydarExecutive Officer
  • Eric BensonExecutive Officer
  • Jon SoderbergDirector
  • Dale GroganDirector
  • Steve MeyerDirector
  • Jon SunthimerDirector
Offering amount
$2.5M
Amount sold
$1.1M
Minimum investment
$5K
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedAug 2022 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary DurackDirector
  • Ryan SheltonExecutive Officer, Director
  • Pablo GonzalezDirector
  • Jon SoderbergDirector
  • Angela McFarlandExecutive Officer
  • Jeff HydarExecutive Officer
  • Jon SunthimerDirector
Offering amount
$3M
Amount sold
$1.3M
Minimum investment
$5K
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.3MraisedSep 2020 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Pablo GonzalezDirector
  • Jon SunthimerDirector
  • Angela McFarlandExecutive Officer
  • Joel WeinsteinDirector
  • Gary DurackDirector
  • Zishan HaroonDirector
  • Jon SoderbergDirector
  • Christian RenaudinDirector
  • Ryan SheltonExecutive Officer, Director
Offering amount
$6.3M
Amount sold
$6.3M
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$260.8KraisedAug 2019 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary DurackDirector
  • Zishan HaroonDirector
  • Joel WeinsteinDirector
  • Christian RenaudinDirector
  • Ryan SheltonExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$260.8K
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2018 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan NolanDirector
  • Joel WeinsteinDirector
  • Gary DurackDirector
  • Ryan SheltonExecutive Officer, Director
  • Christian RenaudinDirector
  • Zishan HaroonDirector
Offering amount
$2M
Amount sold
$2M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJun 2015 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary DurackDirector
  • Stephen BoppartExecutive Officer
  • Ryan SheltonExecutive Officer, Director
Offering amount
$500K
Amount sold
$250K
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2.2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$223.9K
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$2.2M
National Science FoundationPhase I2016$150K
National Institutes of Health (NIH)National Institutes of HealthPhase II2015$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Photonicare do?
PhotoniCare develops OtoSight, an FDA-cleared optical coherence tomography device for non-invasive assessment and monitoring of middle ear infections in healthcare facilities. The technology is designed for physicians treating ear-related conditions and offers improved accuracy over traditional otoscope methods.
Who founded Photonicare?
Photonicare was founded by Ryan Shelton, Stephen Boppart.
Who are Photonicare's investors?
Photonicare's investors include First Leaf Capital, Healthtech Capital, Illinois Ventures, Michigan Capital Network, Michigan Rise, OSF Ventures, Plains Ventures, Sony Ventures Corporation.
How much funding has Photonicare raised?
Photonicare has disclosed $19.9M raised across 8 rounds.
Where is Photonicare headquartered?
Photonicare is headquartered in Durham, US.